Low
₹582.00
High
₹594.05
| Previous Close | ₹587.50 |
|---|---|
| Day's Range | ₹582.00 - ₹594.05 |
| Open | ₹585.25 |
| 52 Week Range | ₹515.00 - ₹894.40 |
| Volume | 21,518 |
| Market Cap | ₹0.00 |
| Previous Close | ₹588.40 |
|---|---|
| Day's Range | ₹582.05 - ₹594.45 |
| Open | ₹594.00 |
| 52 Week Range | ₹502.20 - ₹891.80 |
| Volume | 852 |
| Market Cap | ₹0.00 |
| Trade Value ( ₹ in Lacs) | 126.42 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.47 |
| Price/Earning (TTM) | 23.81 |
| TTM EPS (₹) | 24.78 |
| P/E Ratio | 32.68 |
| Book Value(₹) | 2.04 |
| PAT Margin (%) | 10.82 |
| Face Value (₹) | 5.00 |
| ROCE(%) | 12.39 |
| Trade Value ( ₹ in Lacs) | 5.01 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.47 |
| Price/Earning (TTM) | 23.81 |
| TTM EPS (₹) | 24.78 |
| P/E Ratio | 32.68 |
| Book Value(₹) | 2.04 |
| PAT Margin (%) | 10.82 |
| Face Value (₹) | 5.00 |
| ROCE(%) | 12.39 |
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 1745.12 | 5900.19 |
| Expenses | N/A | N/A |
| PBT | 254.78 | 719.45 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 194.15 | 585.62 |
| Founded | 2010 |
|---|---|
| Managing Director | Yash Mutha |
| NSE Symbol | KRSNAA |
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,37,662.69 | 1,816.00 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,75,692.42 | 6,650.75 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,43,908.69 | 4,293.00 | 3,101.60 - 3,101.60 |
| Apollo Hospitals Enterprise Ltd. | 1,11,261.29 | 7,760.00 | 6,677.50 - 6,677.50 |
| Cipla Ltd. | 1,07,826.86 | 1,330.00 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,07,499.64 | 1,271.60 | 1,129.40 - 1,129.40 |
| Lupin Ltd. | 1,07,489.16 | 2,344.50 | 1,836.80 - 1,836.80 |
| Max Healthcare Institute Ltd. | 98,438.74 | 1,003.05 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 93,323.97 | 2,329.00 | 1,909.70 - 1,909.70 |
| Zydus Lifesciences Ltd. | 90,727.09 | 919.85 | 835.50 - 835.50 |
No Records Found
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Krsnaa Diagnostics has informed that it enclosed copies of notice given to the Members of the Company in accordance with the applicable provisions of the Companies Act, 2013, read with the Rules issued thereunder, and the Listing Regulations, informing them about the resolution proposed to be passed by Postal Ballot through e-voting process only and details thereof. The advertisements published today, March 17, 2026, in the newspapers: Financial Express, English newspaper and Loksatta, Marathi newspaper. This will also be hosted on Company’s website at www.krsnaadiagnostics.com/investors.
The above information is a part of company’s filings submitted to BSE.
Pursuant to Regulation 47 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Krsnaa Diagnostics has informed that it enclosed copies of the newspaper advertisement pertaining to the Unaudited (Standalone and Consolidated) Financial Results for the quarter and nine months ended December 31, 2025. The advertisements are published on February 07, 2026 in the Newspapers: Financial Express, English newspaper and Loksatta, Marathi newspaper. This will also be hosted on the Company’s website at www.krsnaadiagnostics.com/investors.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The current share price of Krsnaa Diagnostics Ltd. is ₹587.50 as of 2026-05-05.
The market capitalisation of Krsnaa Diagnostics Ltd. is ₹1,914.21 as of 2026-05-04.
The 1-year return of Krsnaa Diagnostics Ltd. is -1.60% as of 2026-05-05.
The P/E ratio of Krsnaa Diagnostics Ltd. is 32.68 as of 2026-05-05.
The 52-week high and low of Krsnaa Diagnostics Ltd. are ₹894.40 and ₹515.00, respectively, as of 2026-05-05.
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.